CorMedix Inc. — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 32 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$129M↑+312.1%$14M46.0%
2025-09-30$104M↑+810.2%$109M↑+4009.6%49.2%
2025-06-30$40M↑+4829.4%$20M↑+240.1%49.2%
2025-03-31$39M$21M↑+242.7%51.5%
2024-12-31$31M
2024-09-30$11M$-3M↑+71.5%-28.7%
2024-06-30$806K$-14M↓-25.5%-1898.1%
2024-03-31$-14M↓-36.9%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$129M
↑+312.1% +$97M YoY
Net Income
$14M
↓-50.5% -$14M YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 63 quarters

margin trajectory tells the operating-leverage story
Gross Margin↓-11.1pts
83.4%
Operating Margin
46.0%
Net Margin
10.9%

Go deeper